| |
Control
(n=10 ) |
DME group |
P-values*† |
| SDRT
(n=27 ) |
CME
(n=18 ) |
SRD
(n=15) |
Combined
(n=16) |
All
(n=76) |
DME vs. control* |
Among 4 DME groups† |
| IL-6 |
2.08±1.67
(0.16-4.68) |
69.22±51.22
(10.45-231.37) |
114.31±31.42
(73.93-189.23) |
36.01±26.19
(6.36-89.32) |
98.09±34.66
(38.25-189.32) |
79.42±47.89
(6.36-231.37) |
<0.001 |
<0.001 |
| IL-8 |
6.14±2.45
(3.28-0.04) |
25.86±18.17
(8.34-84.13) |
26.34±9.99
(11.65-44.87) |
22.70±10.66
(10.91-40.69) |
20.87±11.34
(9.98-48.67) |
24.30±13.74
(8.34-84.13) |
<0.001 |
0.531 |
| IL-10 |
0.43±0.47
(0.04-1.53) |
1.18±0.79
(0.09-2.69) |
1.48±1.01
(0.19-4.20) |
1.71±1.17
(0.43-5.56) |
1.50±0.75
(0.43-3.12) |
1.42±0.92
(0.09-5.56) |
<0.001 |
0.556 |
| IL-13 |
0.78±0.31
(0.32-1.31) |
0.93±0.38
(0.32-2.36) |
0.94±0.23
(0.53-1.45) |
0.95±0.29
(0.48-1.65) |
1.05±0.23
(0.70-1.45) |
0.96±0.30
(0.32-2.36) |
<0.001 |
0.447 |
| MCP-1 |
723.25±146.24
(531.74–892.33) |
1812.69±393.42
(1277.65-2495.45) |
2195.58±382.52
(1556.76-2796.34) |
1594.62±327.88
(1129.78-2137.33) |
1690.53±448.40
(1032.45-2455.34) |
1834.61±441.08
(1032.45-2796.34) |
<0.001 |
0.001 |
| VEGF |
21.91±9.42
(10.98-36.55) |
54.71±15.96
(28.32-89.84) |
50.75±14.68
(23.43-75.34) |
31.97±9.82
(18.49-46.54) |
49.21±21.11
(24.50-98.12) |
48.13±17.72
(18.49-98.12) |
<0.001 |
<0.001 |
